PRLD compared with TRAW: revenue, margins and what each company keeps, and the suppliers and customers both name

PRLDPrelude Therapeutics Inc

Mkt capRevenueRevenue

TRAWTraws Pharma, Inc.

Mkt capRevenueRevenue

Compare

PRLDPrelude Therapeutics Inc

TRAWTraws Pharma, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

PRLDPrelude Therapeutics Inc

3.89▼−5.01%· post 3.89

Mkt cap$309.6MRevenue$6MQ2 FY26Revenue—

TRAWTraws Pharma, Inc.

0.30▼−1.23%· post 0.30

ClosedOct 30 '26

Mkt cap$4.5MRevenue$3MQ2 FY25Revenue$3MFY24

Compare

ClosedOct 30 '26

PRLDPrelude Therapeutics Inc

TRAWTraws Pharma, Inc.

3.89▼−5.01%post 3.89

Price

0.30▼−1.23%post 0.30

$309.6M

Mkt cap

$4.5M

Q2 FY26$6M

Revenue

$3MQ2 FY25

—

Revenue

$3MFY24

PRLD3.89▼−5.01%vsTRAW0.30▼−1.23%ClosedOct 30 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

PRLD, solidTRAW, dashed

Supply-chain overlap

Revenue flow

PRLD: latest quarter is a loss; flow not drawable. TRAW: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PRLD 3

INCYIncytecustomer

ABCLAbCellera Biologicscustomer

—Pathos AIunlistedcustomer

Shared 0

No shared counterparties.

Only TRAW 3

—Temple Universityunlistedsupplier

—Viriomunlistedsupplier

—HanX Biopharmaceuticalsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR